StockCode
688506
Investors
中文 | EN

Professor Li Wenbin:The First Clinical Study on GBM by Tetra-specific Antibody Drug Immunotherapy May Change the Survival Situation of the Patients alive with tumour

时间:2023-01-07

Compiled by: Oncology News
Source: Oncology News

李文斌01.jpg

李文斌02.jpg

Systimmune
Baili Pharmaceutical
Guorui Pharmaceutical
Baili-Bio
Jingxi Pharmaceutical
Hiatt Technology
Company Address:1#, Building 1,No.161, Baili Road, Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City
Postcode:610041
Tel:028-85183639
Sichuan Biokin Pharmaceuticals Co.,Ltd Copyright © 2018 All rights reserved
SICPB No. 17035664-1   
Internet Drug Information Service Qualification Certificate S/N: (C)-FJYX-2022-0343